Recognizing early signs in the translational phase is essential for drug development in cardiovascular medicine

ESC Heart Fail. 2023 Aug;10(4):2147-2149. doi: 10.1002/ehf2.14402. Epub 2023 May 10.

Authors

Zoltán Papp¹, Piero Pollesello², Attila Borbély^{1

3}

Affiliations

¹ Department of Cardiology, Division of Clinical Physiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
² Content and Communications Function, Orion Pharma, Espoo, Finland.
³ Department of Cardiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.

No abstract available

Publication types

Editorial

MeSH terms

Cardiovascular Agents*
Cardiovascular Diseases* / diagnosis
Cardiovascular Diseases* / drug therapy
Drug Development
Humans

Substances

Cardiovascular Agents